دورية أكاديمية
Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.
العنوان: | Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect. |
---|---|
المؤلفون: | Kitamura, Yoshiaki1,2, Kito, Seiya1, Nakashima, Remi1, Tanaka, Katsuki1, Nagaoka, Kumi3, Kitade, Yukio1,2,3,4 ykkitade@gifu-u.ac.jp |
المصدر: | Bioorganic & Medicinal Chemistry. Aug2016, Vol. 24 Issue 16, p3870-3874. 5p. |
مصطلحات موضوعية: | *RIBONUCLEASE L, *OLIGOADENYLATES, *TUMOR suppressor genes, *CERVICAL cancer, *BINDING sites |
مستخلص: | RNase L is activated by 2′,5′-oligoadenylates (2-5A) at subnanomolar levels to cleave single-stranded RNA. We previously reported the hypothesis that the introduction of an 8-methyladenosine residue at the 2′-terminus of the 2-5A tetramer shifts the 2-5A binding site of RNase L. In this study, we synthesized various 5′-modified 2-5A analogs with 8-methyladenosine at the 2′-terminus. The doxifluridine-conjugated 8-methyladenosine-substituted 2-5A analog was significantly more effective as an activator of RNase L than the parent 5′-monophophorylated 2-5A tetramer and showed a tumor suppressive effect against human cervical cancer cells. [ABSTRACT FROM AUTHOR] |
قاعدة البيانات: | Academic Search Index |
ResultId |
1 |
---|---|
Header |
asx Academic Search Index 116864391 1243 6 Academic Journal academicJournal 1242.88415527344 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=116864391&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
|
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Kitamura%2C+Yoshiaki%22">Kitamura, Yoshiaki</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kito%2C+Seiya%22">Kito, Seiya</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Nakashima%2C+Remi%22">Nakashima, Remi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Katsuki%22">Tanaka, Katsuki</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Nagaoka%2C+Kumi%22">Nagaoka, Kumi</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kitade%2C+Yukio%22">Kitade, Yukio</searchLink><relatesTo>1,2,3,4</relatesTo><i> ykkitade@gifu-u.ac.jp</i> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Bioorganic+%26+Medicinal+Chemistry%22">Bioorganic & Medicinal Chemistry</searchLink>. Aug2016, Vol. 24 Issue 16, p3870-3874. 5p. ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22RIBONUCLEASE+L%22">RIBONUCLEASE L</searchLink><br />*<searchLink fieldCode="DE" term="%22OLIGOADENYLATES%22">OLIGOADENYLATES</searchLink><br />*<searchLink fieldCode="DE" term="%22TUMOR+suppressor+genes%22">TUMOR suppressor genes</searchLink><br />*<searchLink fieldCode="DE" term="%22CERVICAL+cancer%22">CERVICAL cancer</searchLink><br />*<searchLink fieldCode="DE" term="%22BINDING+sites%22">BINDING sites</searchLink> ) Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => RNase L is activated by 2′,5′-oligoadenylates (2-5A) at subnanomolar levels to cleave single-stranded RNA. We previously reported the hypothesis that the introduction of an 8-methyladenosine residue at the 2′-terminus of the 2-5A tetramer shifts the 2-5A binding site of RNase L. In this study, we synthesized various 5′-modified 2-5A analogs with 8-methyladenosine at the 2′-terminus. The doxifluridine-conjugated 8-methyladenosine-substituted 2-5A analog was significantly more effective as an activator of RNase L than the parent 5′-monophophorylated 2-5A tetramer and showed a tumor suppressive effect against human cervical cancer cells. [ABSTRACT FROM AUTHOR] ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.bmc.2016.06.033
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 5
[StartPage] => 3870
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => RIBONUCLEASE L
[Type] => general
)
[1] => Array
(
[SubjectFull] => OLIGOADENYLATES
[Type] => general
)
[2] => Array
(
[SubjectFull] => TUMOR suppressor genes
[Type] => general
)
[3] => Array
(
[SubjectFull] => CERVICAL cancer
[Type] => general
)
[4] => Array
(
[SubjectFull] => BINDING sites
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kitamura, Yoshiaki
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kito, Seiya
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nakashima, Remi
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tanaka, Katsuki
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nagaoka, Kumi
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kitade, Yukio
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 15
[M] => 08
[Text] => Aug2016
[Type] => published
[Y] => 2016
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 09680896
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 24
)
[1] => Array
(
[Type] => issue
[Value] => 16
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Bioorganic & Medicinal Chemistry
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |